The Complete List and Analysis of the Best Pharmaceutical Companies for Diabetes in 2017
The global diabetes therapeutics market in 2017 was estimated at USD 33 billion and projected to grow at CAGR of 7.5% to reach USD 44.53 billion by 2021. The top 10 diabetes drugs accounted for revenue of USD 29.92 billion in 2017. Merck, dominates the diabetes market, with its best-selling product, Januvia / Janumet.
Sources: SEC filings, companies websites, and annual reports.Top 10 Pharmaceutical Companies 2018 – Diabetes last edit: 2018-05-19T06:12:27+00:00 da